- Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) - Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)
Disciplines :
Neurology Genetics & genetic processes
Author, co-author :
Sugier, Pierre-Emmanuel
Lucotte, Elise A.
Domenighetti, Cloé
Law, Matthew H.
Iles, Mark M.
Brown, Kevin
Amos, Christopher
McKay, James D.
Hung, Rayjean J.
Karimi, Mojgan
Bacq-Daian, Delphine
Boland-Augé, Anne
Olaso, Robert
Deleuze, Jean-François
Lesueur, Fabienne
Ostroumova, Evgenia
Kesminiene, Ausrele
de Vathaire, Florent
Guénel, Pascal
consortium, The Epithyr
Sreelatha, Ashwin Ashok Kumar
Schulte, Claudia
Grover, Sandeep
May, Patrick ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core
Bobbili, Dheeraj Reddy ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core
Radivojkov-Blagojevic, Milena
Lichtner, Peter
Singleton, Andrew B.
Hernandez, Dena G.
Edsall, Connor
Mellick, George D.
Zimprich, Alexander
Pirker, Walter
Rogaeva, Ekaterina
Lang, Anthony E.
Koks, Sulev
Taba, Pille
Lesage, Suzanne
Brice, Alexis
Corvol, Jean-Christophe
Chartier-Harlin, Marie-Christine
Mutez, Eugénie
Brockmann, Kathrin
Deutschländer, Angela B.
Hadjigeorgiou, Georges M.
Dardiotis, Efthimios
Stefanis, Leonidas
Simitsi, Athina Maria
Valente, Enza Maria
Petrucci, Simona
Straniero, Letizia
Zecchinelli, Anna
Pezzoli, Gianni
Brighina, Laura
Ferrarese, Carlo
Annesi, Grazia
Quattrone, Andrea
Gagliardi, Monica
Matsuo, Hirotaka
Nakayama, Akiyoshi
Hattori, Nobutaka
Nishioka, Kenya
Chung, Sun Ju
Kim, Yun Joong
Kolber, Pierre
van de Warrenburg, Bart P. C.
Bloem, Bastiaan R.
Aasly, Jan
Toft, Mathias
Pihlstrøm, Lasse
Guedes, Leonor Correia
Ferreira, Joaquim J.
Bardien, Soraya
Carr, Jonathan
Tolosa, Eduardo
Ezquerra, Mario
Pastor, Pau
Diez-Fairen, Monica
Wirdefeldt, Karin
Pedersen, Nancy
Ran, Caroline
Belin, Andrea C.
Puschmann, Andreas
Rödström, Emil Ygland
Clarke, Carl E.
Morrison, Karen E.
Tan, Manuela
Krainc, Dimitri
Burbulla, Lena F.
Farrer, Matt J.
Krüger, Rejko ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
Gasser, Thomas
Sharma, Manu
Landoulsi, Zied ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core
Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X. Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open 2021;11(7):e046329.
Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson's disease: a meta-analysis. Arch Gerontol Geriatr 2015;61(3):510–516.
Elbaz A, Peterson BJ, Yang P, et al. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002;13(2):157–164.
Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease. Cancer Causes Control 2007;18(7):705–711.
Cui X, Liew Z, Hansen J, Lee PC, Arah OA, Ritz B. Cancers preceding Parkinson's disease after adjustment for bias in a Danish population-based case-control study. Neuroepidemiology 2019;52(3–4):136–143.
Hayes-Larson E, Shaw C, Ackley SF, et al. The role of dementia diagnostic delay in the inverse cancer-dementia association. J Gerontol, Ser A 2022;77(6):1254–1260.
Ospina-Romero M, Glymour MM, Hayes-Larson E, et al. Association between Alzheimer disease and cancer with evaluation of study biases: a systematic review and meta-analysis. JAMA Netw Open 2020;3(11):e2025515–e2025515.
Mencke P, Hanss Z, Boussaad I, Sugier PE, Elbaz A, Krüger R. Bidirectional relation between Parkinson's disease and glioblastoma multiforme. Front Neurol 2020;11:898.
Filippou PS, Outeiro TF. Cancer and Parkinson's disease: common targets, emerging hopes. Mov Disord 2021;36(2):340–346.
Moriarty N, Moriarty J. Highlighting the link between Parkinson's disease and malignant melanoma: a case report and literature review. Eur J Case Reports Intern Med 2019;6(11):1.
Inzelberg R, Flash S, Friedman E, Azizi E. Cutaneous malignant melanoma and Parkinson disease: common pathways? Ann Neurol 2016;80(6):811–820.
Jiang ZC, Chen XJ, Zhou Q, Gong XH, Chen X, Wu WJ. Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway. Int J Oncol 2019;55(1):21–34.
Xu L, Lin DC, Yin D, Koeffler HP. An emerging role of PARK2 in cancer. J Mol Med 2014;92(1):31–42.
Bartek J, Hodny Z. PARK2 orchestrates cyclins to avoid cancer. Nat Genet 2014;46(6):527–528.
Warø BJ, Aasly JO. Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease. Brain Behav 2018;8(1):e00858.
Inzelberg R, Samuels Y, Azizi E, et al. Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma. Neurol Genet 2016;2(3):e70.
Devine MJ, Plun-Favreau H, Wood NW. Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer 2011;11(11):812–823.
Senkevich K, Bandres-Ciga S, Yu E, Liyanage UE, Noyce AJ, Gan-Or Z. No evidence for a causal relationship between cancers and Parkinson's disease. J Parkinsons Dis 2021;11(2):801–809.
Dong J, Gao J, Nalls M, et al. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. Neurobiol Aging 2014;35(6):1512.e5–1512.e10.
Dube U, Ibanez L, Budde JP, et al. Overlapping genetic architecture between Parkinson disease and melanoma. Acta Neuropathol 2020;139(2):347–364.
Forés-martos J, Boullosa C, Rodrigo-domínguez D, et al. Transcriptomic and genetic associations between alzheimer's disease, parkinson's disease, and cancer. Cancers 2021;13(12):2990.
Domenighetti C, Sugier PE, Sreelatha AAK, et al. Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson's disease. J Parkinsons Dis 2022;12(1):267–282.
Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 2019;18(12):1091–1102.
Blauwendraat C, Iwaki H, Makarious MB, et al. Investigation of autosomal genetic sex differences in Parkinson's disease. Ann Neurol 2021;90(1):35–42.
Michailidou K, Lindström S, Dennis J, et al. Association analysis identifies 65 new breast cancer risk loci. Nature 2017;551(7678):92–94.
Law MH, Bishop DT, Lee JE, et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet 2015;47(9):987–995.
Schumacher FR, Al Olama AA, Berndt SI, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet 2018;50(7):928–936.
McKay JD, Hung RJ, Han Y, et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet 2017;49(7):1126–1132.
Phelan CM, Kuchenbaecker KB, Tyrer JP, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet 2017;49(5):680–691.
Truong T, Lesueur F, Sugier PE, et al. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium. Int J Cancer 2021;148(12):2935–2946.
Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet 2015;47(11):1236–1241.
Liyanarachchi S, Gudmundsson J, Ferkingstad E, et al. Assessing thyroid cancer risk using polygenic risk scores. Proc Natl Acad Sci U S A 2020;117(11):5997–6002.
Mavaddat N, Michailidou K, Dennis J, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 2019;104(1):21–34.
Yang X, Leslie G, Gentry-Maharaj A, et al. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. J Med Genet 2018;55(8):546–554.
König IR, Loley C, Erdmann J, Ziegler A. How to include chromosome X in your genome-wide association study. Genet Epidemiol 2014;38(2):97–103.
Gu F, Chen TH, Pfeiffer RM, et al. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Hum Mol Genet 2018;27(3):4145–4156.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539–1558.
Johnson T. Efficient calculation for multi-SNP genetic risk scores. 2012.
Chang D, Nalls MA, Hallgrímsdóttir IB, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. Nat Genet 2017;49(10):1511–1516.
Chen C, Zheng H, Hu Z. Association between Parkinson's disease and risk of prostate cancer in different populations: an updated meta-analysis. Sci Rep 2017;7(1):1–6.
Rashkin SR, Graff RE, Kachuri L, et al. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun 2020;11(1):1–14.
Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31(2–3):139–148.